[1]CurrentPatentAssignee:CALLIDITASTHERAPEUTICSAB-WO2016/189501,2016,A1Locationinpatent:Page/Pagecolumn19
Title: Dual oxidase: a novel therapeutic target in allergic disease.
Journal: British journal of pharmacology 20180501
Title: Cholesteryl ester-transfer protein inhibitors stimulate aldosterone biosynthesis in adipocytes through Nox-dependent processes.
Journal: The Journal of pharmacology and experimental therapeutics 20150401
Title: Inhibition of NOX1/4 with GKT137831: a potential novel treatment to attenuate neuroglial cell inflammation in the retina.
Journal: Journal of neuroinflammation 20150101
Title: Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent.
Journal: Hepatology (Baltimore, Md.) 20121201
Title: The Nox4 inhibitor GKT137831 attenuates hypoxia-induced pulmonary vascular cell proliferation.
Journal: American journal of respiratory cell and molecular biology 20121101
Title: Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo.
Journal: Free radical biology & medicine 20120715
Title: Aoyama T, et al. Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent. Hepatology. 2012 Dec;56(6):2316-27.
Title: Green DE, et al. The Nox4 inhibitor GKT137831 attenuates hypoxia-induced pulmonary vascular cell proliferation. Am J Respir Cell Mol Biol. 2012 Nov;47(5):718-26.
